Pancreatic Cancer Research

ResearcherYamaguchi UniversityNo recent work listed

Byron Baron

Matched on ORCID iD 0000-0001-5722-6295; OpenAlex author ID A5033744969. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: 6 papers · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers

Papers 14

  1. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Co-author DOI 10.1038/s41598-021-90077-x↗
  2. A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.3892/ol.2021.12915↗
  3. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.12961↗
  4. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells. Co-author DOI 10.21873/invivo.11305↗
  5. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.3892/ijo.2016.3804↗
  6. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through I… Co-author DOI 10.1007/s11523-015-0370-0↗
  7. Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration. Co-author DOI 10.1016/j.canlet.2015.02.015↗
  8. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment. Co-author PMID 25770187↗
  9. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer. Co-author PMID 25770192↗
  10. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. Co-author PMID 25862846↗
  11. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells. First author PMID 26504030↗
  12. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0109076↗
  13. Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells. Co-author PMID 25202061↗
  14. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells. Co-author PMID 24222118↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yasuhiro Kuramitsu · 14 shared papers, 2013–2021 · strength 1.00
  2. Kazuyuki Nakamura · 9 shared papers, 2013–2017 · strength 0.48
  3. Yufeng Wang · 7 shared papers, 2013–2017 · strength 0.35
  4. Yoshihiko Maehara · 7 shared papers, 2013–2017 · strength 0.35
  5. Shajedul Islam · 2 shared papers, 2021 · strength 0.30
  6. Keisuke Kuhara · 2 shared papers, 2018–2021 · strength 0.21
  7. Yoshihiro Abiko · 1 shared paper, 2021 · strength 0.16
  8. Masayuki Tokunaga · 2 shared papers, 2015–2018 · strength 0.13
  9. Takuya Shimada · 1 shared paper, 2018 · strength 0.10
  10. Isao Sakaida · 2 shared papers, 2013–2014 · strength 0.07
  11. Shigeyuki Suenaga · 2 shared papers, 2013–2014 · strength 0.07
  12. Masaru Terasaki · 1 shared paper, 2018 · strength 0.07
  13. Masaaki Oka · 1 shared paper, 2015 · strength 0.05
  14. Junya Nawata · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.